LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arte… Read more
Market Cap & Net Worth: LeMaitre Vascular Inc (LMAT)
LeMaitre Vascular Inc (NASDAQ:LMAT) has a market capitalization of $2.55 Billion ($2.55 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #4984 globally and #3021 in its home market, demonstrating a 1.96% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LeMaitre Vascular Inc's stock price $112.23 by its total outstanding shares 22685994 (22.69 Million).
LeMaitre Vascular Inc Market Cap History: 2015 to 2026
LeMaitre Vascular Inc's market capitalization history from 2015 to 2026. Data shows growth from $358.56 Million to $2.55 Billion (24.21% CAGR).
Index Memberships
LeMaitre Vascular Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.09% | #127 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.01% | #591 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.36 Trillion | 0.15% | #268 of 602 |
Weight: LeMaitre Vascular Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
LeMaitre Vascular Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LeMaitre Vascular Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
9.51x
LeMaitre Vascular Inc's market cap is 9.51 times its annual revenue
169.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
47.47x
LeMaitre Vascular Inc's market cap is 47.47 times its annual earnings
862.31x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $358.56 Million | $78.35 Million | $7.76 Million | 4.58x | 46.22x |
| 2016 | $532.33 Million | $89.15 Million | $10.59 Million | 5.97x | 50.27x |
| 2017 | $673.80 Million | $100.87 Million | $17.18 Million | 6.68x | 39.23x |
| 2018 | $504.48 Million | $105.57 Million | $22.94 Million | 4.78x | 21.99x |
| 2019 | $775.71 Million | $117.23 Million | $17.93 Million | 6.62x | 43.25x |
| 2020 | $885.02 Million | $129.37 Million | $21.22 Million | 6.84x | 41.71x |
| 2021 | $1.11 Billion | $154.42 Million | $26.91 Million | 7.17x | 41.15x |
| 2022 | $1.03 Billion | $161.65 Million | $20.64 Million | 6.34x | 49.68x |
| 2023 | $1.28 Billion | $193.48 Million | $30.11 Million | 6.60x | 42.43x |
| 2024 | $2.09 Billion | $219.86 Million | $44.04 Million | 9.51x | 47.47x |
Competitor Companies of LMAT by Market Capitalization
Companies near LeMaitre Vascular Inc in the global market cap rankings as of March 18, 2026.
Key companies related to LeMaitre Vascular Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $170.40 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #263 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #362 globally with a market cap of $61.18 Billion USD ( €59.61 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #472 globally with a market cap of $45.90 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $170.40 Billion | $482.76 |
| #263 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #362 | EssilorLuxottica S. A. | PA:EL | $61.18 Billion | €203.00 |
| #472 | Becton Dickinson and Company | NYSE:BDX | $45.90 Billion | $161.64 |
LeMaitre Vascular Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, LeMaitre Vascular Inc's market cap moved from $358.56 Million to $ 2.55 Billion, with a yearly change of 24.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.55 Billion | +38.38% |
| 2025 | $1.84 Billion | -11.98% |
| 2024 | $2.09 Billion | +63.63% |
| 2023 | $1.28 Billion | +24.60% |
| 2022 | $1.03 Billion | -7.40% |
| 2021 | $1.11 Billion | +25.10% |
| 2020 | $885.02 Million | +14.09% |
| 2019 | $775.71 Million | +53.77% |
| 2018 | $504.48 Million | -25.13% |
| 2017 | $673.80 Million | +26.58% |
| 2016 | $532.33 Million | +48.46% |
| 2015 | $358.56 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of LeMaitre Vascular Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.55 Billion USD |
| MoneyControl | $2.55 Billion USD |
| MarketWatch | $2.55 Billion USD |
| marketcap.company | $2.55 Billion USD |
| Reuters | $2.55 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.